Acne Drug Accutane No Longer Sold
Generic versions of the acne drug, called isotretinoin, are still available from several manufacturers. But Roche, which has sold the drug to 13 million patients since 1982, will not be one of them.
The decision was made for “business reasons,” Roche announced in a news release. Those reasons include declining sales: Accutane sales now make up less than 5% of the isotretinoin market.
You might also be interested in:
- Accutane Lawsuit Over Inflammatory Bowel Disease Results in $25M Verdict
- Acne Drug Accutane No Longer Sold
- Judge Upholds $25M Award in Accutane Bowel Disease Lawsuit
- Hagens Berman Applauds $2 Million Verdict in Accutane Lawsuit
- Settlement of Accutane Lawsuit Reached Prior to Trial
- Roche scores Accutane victory with reversal of $25M verdict
Another big reason: Accutane personal injury lawsuits, which Roche is aggressively defending.
Accutane and other isotretinoin products are effective treatments for serious acne. But the drug can have extremely serious side effects: mental health problems — including depression, psychosis, and suicide — and, when taken by pregnant women, miscarriage or birth defects.
See the full, original post here: https://www.webmd.com/skin-problems-and-treatments/acne/news/20090708/accutane-off-the-market
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement loans and post-settlement loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation lawsuits, mass tort litigation, and multidistrict litigation. We also provide post-settlement funding to attorneys and loans for law firms.
|Other Mass Tort Litigation Funding||Other Multidistrict Litigation Funding|
Click here to see the original article.